Philip Morris (PM) Q4 Highlights: Smoke-Free Growth, Analyst Watchpoints

Philip Morris (PM) reported Q4 driven by double-digit volume gains in IQOS, ZYN, and VIVE across regions, with five consecutive quarters of positive volumes. CEO Jacek Olczak attributed growth to accelerated adoption of smoke-free alternatives, while combustibles showed resilience despite industry normalization and supply chain disruptions in Turkey. Key analyst watchpoints: U.S. approvals and regulatory developments for ZYN Ultra and IQOS ILUMA; impact of escalating Japanese excise taxes on IQOS growth and pricing; and continued adoption in emerging and established markets. Digitalization and cost efficiency are critical to maintaining margin expansion. PM is trading at $188.29, up from $182 pre-earnings (February 13, 2026).